Luis Diaz
Director/Board Member en QUEST DIAGNOSTICS INCORPORATED .
Fortuna: 182 228 $ al 31/03/2024
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| James Davis | M | 61 | 11 años | |
| Victor Velculescu | M | - |
Personal Genome Diagnostics, Inc.
 Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | 14 años |
| Megan Bailey | F | - |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | 6 años |
| Denise Morrison | F | 70 | 5 años | |
| Eric Laub | M | - | 3 años | |
| Lily Li | M | - |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | - |
| Michael Deppe | M | 59 | 26 años | |
| Jacquelyn Sandell | F | - | 5 años | |
| Kavita Patel | M | 50 |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | - |
| Wright Lassiter | M | 60 | 4 años | |
| James T. LaFrance | M | 65 |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | 7 años |
| Peter Klein | M | 46 |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | - |
| Catherine Doherty | F | 61 | 34 años | |
| Tracey Doi | F | 63 | 3 años | |
| Vicky Gregg | F | 69 | 10 años | |
| Timothy Ring | M | 66 | 13 años | |
| Michael Prevoznik | M | 62 | 25 años | |
| Gail Wilensky | M | 80 | 27 años | |
| Gary Pfeiffer | M | 74 | 20 años | |
| Timothy Main | M | 66 | 10 años | |
| Dennis Moynihan | M | - | - | |
| Sean Mersten | M | - | - | |
| Kristin Wallace | F | - | - | |
| Mark Delaney | M | - | 2 años | |
| Maura Kadan | F | - |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | - |
| Bert Vogelstein | M | - |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | - |
| Patrick Plewman | M | 58 | - | |
| Stephen Milner | M | - |
The Johns Hopkins University School of Medicine
| 19 años |
| Sam Samad | M | 54 | 2 años | |
| Dermot Victor Shorten | M | - | 16 años | |
| Shawn Bevec | M | - | - | |
| Alyssa Waxenberg | F | 53 | 3 años | |
| Doug Lang | M | - | 11 años | |
| Cecilia K. McKenney | F | 61 | 6 años | |
| Tracy L. Cinco-Abela | F | - | 17 años | |
| Gary D. Samuels | M | - | 28 años | |
| Peter Pronovost | M | 59 |
The Johns Hopkins University School of Medicine
| 13 años |
| Yuri Fesko | M | - | 1 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Cary Pfeffer | M | 61 | 8 años | |
| Kimberlee Drapkin | F | 55 | 10 años | |
| Perry Karsen | M | 69 | 7 años | |
| Richard Murray | M | 65 | 9 años | |
| Malin Deon | F | - | - | |
| Sam Small | M | - |
The Johns Hopkins University School of Medicine
| 6 años |
| Robert Iannone | M | 57 | 3 años | |
| Garry Nicholson | M | 69 |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | - |
| Anna L. Barry | M | - | 5 años | |
| Hugh Cole | M | 59 | 6 años | |
| Robert Kamen | M | 79 | 10 años | |
| Barbara Duncan | F | 59 | 7 años | |
| John Duncan Higgons | M | 69 | 7 años | |
| Jigar Raythatha | M | 47 | 2 años | |
| Deborah Law | M | - | 3 años | |
| Mary Margaret Huizinga | M | 47 |
The Johns Hopkins University School of Medicine
| - |
| Haley Laken | M | - | - | |
| Dmitri Wiederschain | M | - | - | |
| Min Li | M | 62 |
The Johns Hopkins University School of Medicine
| 20 años |
| Lauren Lee | M | - |
The Johns Hopkins University School of Medicine
| 4 años |
| Jamie Platt | M | - |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | - |
| Luisa Salter-Cid | M | 60 | 2 años | |
| Emma Lees | M | - | 1 años | |
| Benjamin Carson | M | 73 |
The Johns Hopkins University School of Medicine
| 29 años |
| Douglas Ward | M | - |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | 4 años |
| Douglas Kerr | M | 57 |
The Johns Hopkins University School of Medicine
| 11 años |
| Jay Wohlgemuth | M | - | 7 años | |
| Antony Newton | M | - |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | - |
| Tai-Li Chang | M | - |
The Johns Hopkins University School of Medicine
| 4 años |
| Jonathan M. Ellen | M | - |
The Johns Hopkins University School of Medicine
| 11 años |
| Le Fei Sun | M | 44 |
The Johns Hopkins University School of Medicine
| 1 años |
| Elizabeth G. Trehu | M | 64 | 8 años | |
| Gabrielle Wolfson | F | - | 5 años | |
| Blake Scott | M | - |
The Johns Hopkins University School of Medicine
| 5 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 72 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Luis Diaz
- Red Personal
